Works by Bang, Rikke Beck

Results: 8

Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial

Published in:

2017

By:

Bowering, Keith;
Case, Christopher;
Harvey, John;
Reeves, Michael;
Sampson, Michael;
Strzinek, Robert;
Bretler, Ditte-Marie;
Bang, Rikke Beck;
Bode, Bruce W.

Publication type:

journal article

732-P: CGM-Derived Parameters for Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 in Insulin-Naïve Patients with T2D.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-732-P

By:

LINGVAY, ILDIKO;
BANG, RIKKE BECK;
KOEFOED, METTE M.;
MADER, JULIA K.;
PETTUS, JEREMY;
WAGNER, LILY;
MATHIEU, CHANTAL

Publication type:

Article

731-P: CGM-Based Measurements for Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 in Insulin-Treated Patients with T2D: A Post-hoc Analysis.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-731-P

By:

BAJAJ, HARPREET S.;
BANG, RIKKE BECK;
GOWDA, AMOOLYA;
KOEFOED, METTE M.;
SENIOR, PETER A.;
BERGENSTAL, RICHARD M.

Publication type:

Article

Cover Image, Volume 100, Number 4, April 2024.

Published in:

Clinical Endocrinology, 2024, v. 100, n. 4, p. i, doi. 10.1111/cen.15113

By:

Mori, Jun;
Ohata, Yasuhisa;
Fujisawa, Yasuko;
Sato, Yukihito;
Röhrich, Sebastian;
Rasmussen, Michael Højby;
Bang, Rikke Beck;
Horikawa, Reiko

Publication type:

Article

Effective growth hormone replacement with once‐weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.

Published in:

Clinical Endocrinology, 2024, v. 100, n. 4, p. 389, doi. 10.1111/cen.15025

By:

Mori, Jun;
Ohata, Yasuhisa;
Fujisawa, Yasuko;
Sato, Yukihito;
Röhrich, Sebastian;
Rasmussen, Michael Højby;
Bang, Rikke Beck;
Horikawa, Reiko

Publication type:

Article

Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. 3090, doi. 10.1210/clinem/dgad394

By:

Miller, Bradley S.;
Blair, Joanne C.;
Rasmussen, Michael Højby;
Maniatis, Aristides;
Mori, Jun;
Böttcher, Volker;
Ho-Seong Kim;
Bang, Rikke Beck;
Polak, Michel;
Reiko Horikawa

Publication type:

Article

Response to Letter to the Editor From Chatelain et al: 'Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial'.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. e647, doi. 10.1210/clinem/dgad095

By:

Miller, Bradley S.;
Blair, Joanne C.;
Rasmussen, Michael Højby;
Maniatis, Aristides;
Kildemoes, Rasmus Juul;
Jun Mori;
Polak, Michel;
Bang, Rikke Beck;
Böttcher, Volker;
Stagi, Stefano;
Reiko Horikawa

Publication type:

Article

Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3378, doi. 10.1210/clinem/dgac513

By:

Miller, Bradley S.;
Blair, Joanne C.;
Rasmussen, Michael Højby;
Maniatis, Aristides;
Kildemoes, Rasmus Juul;
Jun Mori;
Polak, Michel;
Bang, Rikke Beck;
Böttcher, Volker;
Stagi, Stefano;
Reiko Horikawa

Publication type:

Article